West Pharmaceutical
338 hedge funds and large institutions have $6.85B invested in West Pharmaceutical in 2017 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 115 increasing their positions, 105 reducing their positions, and 25 closing their positions.
152% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 25
43% more call options, than puts
Call options by funds: $1.15M | Put options by funds: $809K
12% more funds holding
Funds holding: 302 → 338 (+36)
10% more repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 105
2% more capital invested
Capital invested by funds: $6.72B → $6.85B (+$130M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.3% less ownership
Funds ownership: 94.31% → 94% (-0.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$86.3M |
| 2 |
TG
TCW Group
Los Angeles,
California
|
+$39.3M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$37.6M |
| 4 |
BlackRock
New York
|
+$33.5M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$15.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
-$103M |
| 2 |
Jennison Associates
New York
|
-$30.8M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$24.2M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$20.7M |
| 5 |
Neuberger Berman Group
New York
|
-$20.4M |
WST Hedge Fund Activity: Q4 2017 in Review
338 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q4 2017, worth a combined $6.85B — up 1.9% from $6.72B a quarter earlier.
Buyers outnumbered sellers: 63 funds opened new WST positions and 25 closed out — a net gain of 38 holders — while 115 added to existing stakes and 105 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $86.3M. The largest seller was Select Equity Group, cutting an estimated $103M.
- 338 institutional investors held West Pharmaceutical (WST) as of Q4 2017, up from 302 in Q3 2017.
- Funds reported $6.85B of West Pharmaceutical stock for Q4 2017, up 1.9% quarter-over-quarter.
- 63 funds opened new West Pharmaceutical positions in Q4 2017 and 25 closed out, a net change of +38 holders.
- The largest West Pharmaceutical buyer in Q4 2017 was AllianceBernstein, an estimated $86.3M added.
- The largest West Pharmaceutical seller in Q4 2017 was Select Equity Group, an estimated $103M sold.
Based on aggregated 13F filings for Q4 2017.